News | March 06, 2023
Par Drugs and Chemicals receives WHO-GMP certificate
The audit was commenced for newly renovated manufacturing Block 1, Block 2, and Block 3
The audit was commenced for newly renovated manufacturing Block 1, Block 2, and Block 3
The collaboration will focus on developing a localized and sustained-release drug delivery system for oncology patients
The WHO - Global Center for Traditional Medicine will help member countries in taking enabling steps in their countries for strengthen education and practices of traditional mdicine
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
With digitally available health records, individuals can avail paper-less health services under Ayushman Bharat Digital Mission (ABDM)
The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.
Receives regulatory approval for its molecule ‘Selumetinib’ in India
Natco launched pomalidomide under their brand NAT-POMALIDOMIDE in strengths of 1 mg, 2 mg, 3 mg and 4 mg capsules
Amala Hospital partners with LifeSigns to provide revolutionary technology for the first time in the State
Subscribe To Our Newsletter & Stay Updated
